Machine Learning Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676 in… AIT News Desk Feb 6, 2023 Accutar Biotechnology,, a biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announced that the U.S. Food and…
Life Sciences Accutar Biotechnology Announces Fast Track Designation Granted by FDA to AC0176 for the Treatment of… AIT News Desk Jun 2, 2022 Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, announced that…